ScoutQuest28 Sep 2026
Allcargo Logistics532749CEO role change

MD & CEO Ketan Kulkarni resigns to take Group role; Vijay Nehra appointed MD & CEO from January 2027

Leadership change at the top.

Outgoing MD & CEO
Mr. Ketan Kulkarni, resigns effective close of business on December 31, 2026
New Role for Outgoing Leader
Chief Growth Officer for the Allcargo Group from January 01, 2027
Incoming MD & CEO
Mr. Vijay Nehra appointed as Chief Transformation Officer & MD Designate from October 01, 2026
Re-designation Period
Managing Director & CEO for 5 consecutive years from January 01, 2027, subject to shareholder approval
Transition Overlap
October 01, 2026 to December 31, 2026

What was announced

The Governance and Nomination & Remuneration Committee and the Board met on September 28, 2026 and approved a change at the top of the company.

The incoming leader

Mr. Vijay Nehra has been appointed as:

His background

His profile covers general management, business transformation, supply chain and operations across financial services, pharmaceuticals, FMCG, e-commerce and technology-led businesses. Most recently he was CEO of Ozone Pharmaceuticals Group, where he led its transition from a promoter-operated enterprise to a professionally managed organization and led the onboarding of a private equity partner. Earlier he was Chief Operating Officer of RattanIndia Enterprises Limited with P&L responsibility across e-commerce, electric mobility, drones and fintech, and held senior roles in the Indiabulls Group. At Hindustan Unilever Limited he worked across sales, planning, logistics, customer service and supply chain. He began his career as a Master Mariner and Merchant Ship Captain. He holds a Post Graduate Programme in Management from the Indian School of Business, Hyderabad, and a Bachelor of Nautical Sciences from T. S. Chanakya, University of Mumbai.

Points to note

Investors may read a CEO transition either as continuity risk or as a planned succession; here the outgoing MD & CEO stays within the group and a transition period has been built in. The final re-designation as MD & CEO requires shareholder approval.

More numbers
  • Term of appointment as MD & CEO for Mr. Vijay Nehra5 (Five) consecutive years
  • Notice period waiver requested by outgoing MD & CEO6 (six) months'
Source: BSE · 28 Sep 2026

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.